◱ the molecule's journey
one bench,
four doors
A peptide starts the same way every time: amino acids on a resin, in a reactor. Whether it ends up a branded pen, a cash-programme vial, a research-label vial or a pill is not decided by the chemistry. It is decided by which door it leaves through.
the thesis
the price gap is the entire market
The same molecule, made on the same kind of equipment, carries wildly different prices depending on which regulatory lane it travels. The gap has not closed — it has split.
Figures are indicative ranges drawn from public reporting on the category, not quotes, and not an invitation to buy anything.
bench → ocean → border → fork → fridge
the testing reality
what is actually in the vial
Independent testing of consumer-facing peptide products has repeatedly found measured purity far below label claims, and in some samples elemental contamination above limits that would apply to an injectable product. There is no way to know this from a label. Proof lives in the paperwork, and most paperwork does not contain it.
grade a certificate →◆ guardrails
this maps the industry, not the marketplace
This page exists so the structure of the category is legible. It is a reference, not a sourcing tool. Five rules keep that line honest.
- industry anatomy, never a vendor directory
- filings and enforcement patterns, never sourcing instructions
- named parties as objects of study, never as endorsements
- aggregate market mechanics, never personal advice
- no compound named here is offered, recommended, or linked for purchase
go deeper
the regulated tier
The full class-by-class verdict on the molecules that built this market lives in the member briefs.
read the briefs →